Wrexham Academic Unit, Wales College of Medicine, Cardiff University, Wales, UK
Correspondence to: Dr J N Harvey, Senior Lecturer in Diabetes, Endocrinology and Metabolism, Gladstone Centre, Maelor Hospital, Wrexham LL13 7TD, Wales, UK E-mail: john.harvey{at}new-tr.wales.nhs.uk
Objective To review the clinical presentations and diagnostic issues in adrenomyeloneuropathy and adrenoleukodystrophy, which are different presentations of the same single gene disorder.
Design Observational study.
Participants Three generations of an affected kindred.
Intervention None.
Main outcome measures Neurological features suggestive of adrenoleukodystrophy or adrenomyeloneuropathy. Measurement of very long chain fatty acids. Molecular analysis of the adrenoleukodystrophy gene.
Results Three adults presented with adrenomyeloneuropathy and two children with adrenoleukodystrophy. Circulating concentrations of long chain fatty acids were raised consistent with clinical features. A mutation in exon 6 of the adrenoleukodystrophy gene (P543L) was identified. This had not previously been identified but has subsequently been reported by other groups.
Conclusions Adrenomyeloneuropathy should be considered in the differential diagnosis in male patients presenting with adrenal failure. Early diagnosis allows genetic counselling in such families and may become more important as treatment strategies evolve.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Related articles in JRSM: